Verified Nov 2026
Other
·
Saluggia, Piemonte
·
Since 1968
Diasorin is an Italian in vitro diagnostics company headquartered in Saluggia, Piemonte, founded in 1968 and listed on the Italian Stock Exchange under the ticker DIA.MI. It employs between 1,000 and 5,000 people and reports revenue of roughly 1.4 billion. The company develops immunodiagnostic and molecular diagnostic reagent kits and instruments used in clinical testing, serving diagnostic laboratories and healthcare institutions. In April 2026 it signed an exclusive US distribution agreement with McKesson Medical Surgical for its Liaison NES molecular point-of-care platform and its flu A/B, RSV and COVID-19 panel.
Diasorin at a glance
Revenue
1.4B
Employees
1,000-5,000
Founded
1968
Headquarters
Saluggia, Piemonte
Ownership
Publicly traded (MIL: DIA.MI)
Certifications
ISO 13485 · ISO 14001 · ISO 45001 · ISO 9001
Industries
Automotive
Electric Vehicles
Medical
Renewable Energy
Industrial Equipment
STABILITY SIGNALS
Established & strong
58 years in operation (founded 1968).
Publicly listed; no distress event on record.
Holds ISO 13485, ISO 14001, ISO 45001, ISO 9001 certification(s) per public sources.
Overview
Diasorin is an Italian in vitro diagnostics company headquartered in Saluggia, Piemonte, founded in 1968 and listed on the Italian Stock Exchange under the ticker DIA.MI. It employs between 1,000 and 5,000 people and reports revenue of roughly 1.4 billion. The company develops immunodiagnostic and molecular diagnostic reagent kits and instruments used in clinical testing, serving diagnostic laboratories and healthcare institutions. In April 2026 it signed an exclusive US distribution agreement with McKesson Medical Surgical for its Liaison NES molecular point-of-care platform and its flu A/B, RSV and COVID-19 panel.
At a glance
Attribute | Detail |
|---|---|
Founded | 1968 |
Headquarters | Saluggia, Piemonte |
Employees | 1,000-5,000 |
Revenue | 1.4B |
Ownership | Publicly traded (MIL: DIA.MI) |
Certifications | ISO 13485 · ISO 14001 · ISO 45001 · ISO 9001 |
What Diasorin makes
The company holds ISO 9001, ISO 13485, ISO 14001 and ISO 45001 certifications and offers platforms such as the Liaison System and Verigene System for diagnostic testing.
Products and capabilities described on the company's own site include Emissions (source: diasorin.com).
Certifications
Diasorin is associated with the following certifications in public sources. Confirm the certified scope for the specific plant producing your part:
ISO 13485 — diasorin.com
ISO 14001 — diasorin.com
ISO 45001 — diasorin.com
ISO 9001 — diasorin.de
Latest developments
2026-05-20 — Diasorin Lays Out Aggressive Plans for Molecular Diagnostics Growth in the US | GenomeWeb (genomeweb.com)
2026-04-18 — DIASORIN SIGNS STRATEGIC DISTRIBUTION AGREEMENT WITH MCKESSON MEDICAL SURGICAL TO EXPAND ACCESS FOR THE LIAISON NES MOLECULAR POINT-OF-CARE PLATFORM AND THE FLU A/B, RSV & COVID-19 PANEL IN NON‑ACUTE SETTINGS ACROSS THE UNITED STATES | MLO Online (mlo-online.com)
2026-04-03 — DIASORIN SIGNS EXCLUSIVE DISTRIBUTION AGREEMENT FOR THE LIAISON NES® MOLECULAR POINT-OF-CARE PLATFORM AND THE FLU A/B, RSV & COVID-19 PANEL | MLO Online (mlo-online.com)
2026-03-23 — Diasorin Touts €10M US Investment, Pivots China Business as Total 2025 Revenue Grows 1 Percent | GenomeWeb (genomeweb.com)
2026-01-26 — Diasorin, Thermo Fisher Ink US Distribution Pact for Rapid POC Molecular System, Respiratory Test | 360Dx (360dx.com)
2025-11-05 — Diasorin Moves to Expand Test Menu and Shore up Sales as Q3 Revenues Decline | 360Dx (360dx.com)
Company details
Diasorin is publicly listed, and in January 2026 it entered a US distribution agreement with Thermo Fisher for a rapid point-of-care molecular system and respiratory test. Diasorin was founded in 1968, has an estimated 1,000-5,000 employees, and is headquartered in Saluggia, Piemonte. On the LightSource stability read it is rated "Established & strong": 58 years in operation (founded 1968). Publicly listed; no distress event on record. Holds ISO 13485, ISO 14001, ISO 45001, ISO 9001 certification(s) per public sources.
Frequently asked questions
What does Diasorin do?
Diasorin is an Italian in vitro diagnostics company headquartered in Saluggia, Piemonte, founded in 1968 and listed on the Italian Stock Exchange under the ticker DIA.MI. It employs between 1,000 and 5,000 people and reports revenue of roughly 1.4 billion. The company develops immunodiagnostic and molecular diagnostic reagent kits and instruments used in clinical testing, serving diagnostic laboratories and healthcare institutions. In April 2026 it signed an exclusive US distribution agreement with McKesson Medical Surgical for its Liaison NES molecular point-of-care platform and its flu A/B, RSV and COVID-19 panel.
Where is Diasorin headquartered?
Diasorin is headquartered in Saluggia, Piemonte (Via Crescentino, Saluggia, Piemonte, 13040).
When was Diasorin founded?
Diasorin was founded in 1968.
How big is Diasorin?
Diasorin has an estimated 1,000-5,000 employees, with revenue in the 1.4B range.
Is Diasorin publicly traded?
Publicly traded (MIL: DIA.MI). Public financial figures are drawn from its filings.
What certifications does Diasorin hold?
Diasorin lists ISO 13485 · ISO 14001 · ISO 45001 · ISO 9001 on its website. Confirm the certified scope for the specific plant producing your part.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Phone
+1 512-219-8020
Certification
ISO 13485 · ISO 14001 · ISO 45001 · ISO 9001
Evaluating suppliers like these?
This profile comes from a public-data sample of around 1,000 companies. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.